APA (7th ed.) Citation

RB, J., J, F., M, A., KK, P., GW, C., M, Z., . . . JM, S. (2022). Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive Breast Cancer. Cancer research communications, 2(12), 1569. https://doi.org/10.1158/2767-9764.CRC-22-0158

Chicago Style (17th ed.) Citation

RB, Jones, Farhi J, Adams M, Parwani KK, Cooper GW, Zecevic M, Lee RS, Hong AL, and Spangle JM. "Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive Breast Cancer." Cancer Research Communications 2, no. 12 (2022): 1569. https://doi.org/10.1158/2767-9764.CRC-22-0158.

MLA (9th ed.) Citation

RB, Jones, et al. "Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive Breast Cancer." Cancer Research Communications, vol. 2, no. 12, 2022, p. 1569, https://doi.org/10.1158/2767-9764.CRC-22-0158.